Diphenylpyraline hydrochloride - CAS 132-18-3
Catalog number:
132-18-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H23NO.HCl
Molecular Weight:
317.85
COA:
Inquire
Targets:
Histamine Receptor
Description:
The hydrochloride salt form of Diphenylpyraline, one of the first-generation antihistamine agent, has been found to exhibit anticholinergic activity and could be used against Parkinson's disease.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
White to off-white powder
Synonyms:
4-DIPHENYLMETHOXY-1-METHYLPIPERIDINE HYDROCHLORIDE;4-DIPHENYLMETHOXY-1-METHYLPIPERIDINE HYDROCHLORIDE MONOHYDRATE;4-BENZHYDRYLOXY-1-METHYL PIPERIDINE HCL;LABOTEST-BB LT00159897;DIPHENYLPYRALINE HCL;DIPHENYLPYRALINE HYDROCHLORIDE;4-Benzhydryloxy-1-methylp
Solubility:
H2O: > 36 mg/mL
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
The hydrochloride salt form of Diphenylpyraline is one of the first-generation antihistamine agent and has been found to exhibit anticholinergic activity and could be used against Parkinson's disease.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Melting Point:
203-205 °C
InChIKey:
LPRLDRXGWKXRMQ-UHFFFAOYSA-N
InChI:
InChI=1S/C19H23NO.ClH/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17;/h2-11,18-19H,12-15H2,1H3;1H
Canonical SMILES:
CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3.Cl
1.[Efficacy of compound Xuanju Capsule combined with apomorphine hydrochloride on erectile dysfunction].
Wang BQ1. Zhonghua Nan Ke Xue. 2012 Dec;18(12):1108-10.
OBJECTIVE: To investigate the clinical effect of Compound Xuanju Capsule combined with apomorphine hydrochloride on penile erectile dysfunction (ED).
2.Porous silicon-based direct hydrogen sulphide fuel cells.
Dzhafarov TD1, Yuksel SA. J Nanosci Nanotechnol. 2011 Oct;11(10):9012-5.
In this paper, the use of Au/porous silicon/Silicon Schottky type structure, as a direct hydrogen sulphide fuel cell is demonstrated. The porous silicon filled with hydrochlorid acid was developed as a proton conduction membrane. The Au/Porous Silicon/Silicon cells were fabricated by first creating the porous silicon layer in single-crystalline Si using the anodic etching under illumination and then deposition Au catalyst layer onto the porous silicon. Using 80 mM H2S solution as fuel the open circuit voltage of 0.4 V was obtained and maximum power density of 30 W/m2 at room temperature was achieved. These results demonstrate that the Au/Porous Silicon/Silicon direct hydrogen sulphide fuel cell which uses H2S:dH2O solution as fuel and operates at room temperature can be considered as the most promising type of low cost fuel cell for small power-supply units.
3.Effects of pulmonary acid aspiration on the regional pulmonary blood flow within the first hour after injury: An observational study in rats.
Richter T1, Bergmann R2, Pietzsch J2,3, Mueller MP1, Koch T1. Clin Hemorheol Microcirc. 2015 Jul 16;60(2):253-62. doi: 10.3233/CH-141867.
INTRODUCTION: Gastric aspiration events are recognized as a major cause of pneumonitis and the development of acute respiratory distress syndrome. The first peak in the inflammatory response has been observed one hour after acid-induced lung injury in rats. The spatial pulmonary blood flow (PBF) distribution after an acid aspiration event within this time frame has not been adequately studied. We determined therefore PBF pattern within the first hour after acid aspiration.
4.Penetration enhancement of lidocaine hydrochlorid by a novel chitosan coated elastic liposome for transdermal drug delivery.
Li L1, Zhang Y, Han S, Qu Z, Zhao J, Chen Y, Chen Z, Duan J, Pan Y, Tang X. J Biomed Nanotechnol. 2011 Oct;7(5):704-13.
An effective transdermal delivery system for local anaesthetic was developed with lidocaine hydrochloride (LID) as model drug. Chitosan coated elastic liposome (CCEL) were proposed and its in vitro/in vivo skin permeation properties were evaluated. Elastic liposome composed of soya lecithin with sodium deoxycholate (SDC) as edge activator, was prepared by rotary evaporation-sonication method. Chitosan (CH) (0.1-0.5%, w/v) coated elastic liposome by electrostatic attraction of negative elastic liposome and positive CH. CH coating changed the elastic liposome surface charge and increased the vesicle size. The drug encapsulation efficiency (EE) decreased with the increase of CH content. CH coated elastic liposome demonstrated an improved physicochemical stability at 4 degrees C in a 3 months storage period. After coated, CCEL displayed a prolonged drug release profile in vitro release study. The in vitro/in vivo studies showed that CCEL were able to give a statistically significant improvement of skin permeation of LID and significantly reduced pain in comparison with elastic liposome and CH solution.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 21535-47-7 Mianserin Hydrochloride

Mianserin Hydrochloride
(CAS: 21535-47-7)

Mianserin Hydrochloride is a psychoactive drug of the tetracyclic antidepressant.It is classified as a noradrenergic and specific serotonergic antidepressant (N...

CAS 84-96-8 Trimeprazine

Trimeprazine
(CAS: 84-96-8)

Alimemazine is a phenothiazine derivative as a Histamine Receptor antagonist. It can be used as an antipruritic . It also acts as a sedative, hypnotic, and anti...

CAS 135-87-5 Piperoxan.Hcl

Piperoxan.Hcl
(CAS: 135-87-5)

Piperoxan is an antihistamine drug which is derived from benzodioxan. At first it was investigated by Fourneau as an α-adrenergic-blocking agent, then they foun...

CAS 83799-24-0 Fexofenadine

Fexofenadine
(CAS: 83799-24-0)

Fexofenadine is Histamine H1 receptor antagonist. It can be used for the treatment of allergy symptoms, such as hay fever, nasal congestion, and urticaria.

CAS 113-69-9 Benzquinamide Hydrochloride

Benzquinamide Hydrochloride
(CAS: 113-69-9)

Benzquinamide hydrochloride is an antiemetic compound with antihistaminic, anticholinergic and sedative properties. The mechanism of action is not quite sure an...

CAS 34580-13-7 Ketotifen

Ketotifen
(CAS: 34580-13-7)

Ketotifen is a cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators, used as self-medication for the temporary relief of ...

CAS 147084-10-4 Alcaftadine

Alcaftadine
(CAS: 147084-10-4)

Alcaftadine(R89674) is a H1 histamine receptor antagonist, which is used to prevent eye irritation brought on by allergic conjunctivitis.

GSK-239512
(CAS: 720691-69-0)

GSK-239512 is a histamine H3 receptor antagonist. In Jun 2015, Phase-II for Schizophrenia in USA was discontinued. Phase II clinical trilas for the treatment of...

CAS 80012-43-7 Epinastine

Epinastine
(CAS: 80012-43-7)

Epinastine is a second-generation antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. It is highly selective for ...

CAS 82-93-9 Chlorcyclizine

Chlorcyclizine
(CAS: 82-93-9)

Chlorcyclizine is a first-generation Histamine Receptor antagonist of the phenylpiperazine class. It can be used primarily to treat allergy symptoms such as rhi...

LY-150310
(CAS: 103294-47-9)

LY-150310 is a histamine H1-receptor antagonist. It could alter prostanoid concentrations in vitro and in vivo.

CAS 113806-05-6 Olopatadine

Olopatadine
(CAS: 113806-05-6)

This active molecular is an antihistamine, anticholinergic and mast cell stabilizer. Olopatadine blocks the action of endogenous histamine. It is used to treat ...

CAS 100981-43-9 Ebrotidine

Ebrotidine
(CAS: 100981-43-9)

Ebrotidine(FI 3542), a competitive H2-receptor antagonist, has gastroprotective activity under the condition of gastric mucosal damage caused by some stress res...

CAS 459168-41-3 JNJ-7777120

JNJ-7777120
(CAS: 459168-41-3)

JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other h...

CAS 64-89-1 Propiomazine Hydrochloride

Propiomazine Hydrochloride
(CAS: 64-89-1)

Propiomazine Hydrochloride is an antihistamine blocking H1 receptors. It is used to treat insomnia and to produce drowsiness. It is also used to relieve anxiety...

CAS 7456-24-8 Fonazine

Fonazine
(CAS: 7456-24-8)

Dimetotiazine is a histamine H1 receptor antagonist. It is a phenothiazine drug used for the treatment of migraine.

CAS 34839-70-8 Metiamide

Metiamide
(CAS: 34839-70-8)

Metiamide is developed from another burimamide, used as a histamine H2 receptor antagonist.

CAS 108498-50-6 FRG8701

FRG8701
(CAS: 108498-50-6)

FRG-8701 is a novel Histamine H2 receptor antagonist (IC50= 0.25~ 0.43 μM). FRG-8701 has relatively long-lasting antisecretory ef fects in comparison with famot...

CAS 76824-35-6 Famotidine

Famotidine
(CAS: 76824-35-6)

Famotidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroe...

CAS 66357-59-3 Ranitidine

Ranitidine
(CAS: 66357-59-3)

Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease and gastroesoph...

Chemical Structure

CAS 132-18-3 Diphenylpyraline hydrochloride

Quick Inquiry

Verification code

Featured Items